Aurobindo Pharma | ARBP - Cost Of Sales

Stock Price
1,191.15
Daily Change
8.65 0.73%
Monthly
-3.57%
Yearly
-0.05%
Q1 Forecast
1,189.51

Aurobindo Pharma reported INR33.39B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Cipla INR 29.1B 1.16B Dec/2025
Divis Laboratories Ltd INR 11.86B 1.18B Sep/2025
Dr.Reddys Laboratories INR 36.16B 3.75B Dec/2025
Hindustan Unilever INR 82.51B 3.51B Sep/2025
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
UPL INR 66.73B 1.49B Dec/2025